Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialÉtienne Garin, Lambros Tselikas, Boris Guiu et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 602
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinomaBertrand Le Roy, António Sá Cunha, Éric Vibert et al.|British journal of surgery|2017Cited by 255
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trialRené Adam, Céline Piedvache, L. Chiche et al.|The Lancet|2024Cited by 153
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of CirrhosisEléonora De Martin, Éric Vibert, M. Rayar et al.|Liver Transplantation|2020Cited by 122
Molecular targeted therapy of <i>BRAF</i> -mutant colorectal cancerMichel Ducreux, Maximiliano Gelli, Ali N. Chamseddine et al.|Therapeutic Advances in Medical Oncology|2019Cited by 102